phentermine vs retatrutide vs. GLP-1 Injections: What's the Real Difference? retatrutide pen 10mg Disposable Injection

The North American GLP-1 Agonists Market Holds A Significant Revenue Share In The Region

Obesity, 19 (1), 110120

We cover the agencys move to restrict mass-marketed compounded GLP-1 products amid ongoing demand and safety concerns, as well as its decision to roll back certain requirements for isotretinoin-containing acne treatments

We expect to see more pack trade-offs in potato chips, soft drinks and cold cereal but we also see outsized pack trade-offs in coffee and granola, which implies two emerging trends in the GLP-1 population: a general decrease in snacking, even for snacks usually considered healthy, and overall collateral damage that is spreading to categories that should not be greatly affected by GLP-1 status. In addition to their impact on the retail food and beverage market, oral GLP-1 medications are expected to account for 20% of total GLP-1 drug sales by 2031, with a pill market that is estimated to grow from $3.2 billion in 2025 to $34.3 billion in 2031, according to GlobalData.

Other serious side effects include pancreatitis (pancreatic inflammation), the development of thyroid tumors, and gallbladder problems. Research from 2023 shows that semaglutide, such as Ozempic and Wegovy, and tirzepatide, such as Mounjaro and Zepbound, are more effective than liraglutide for weight loss